Supplementary data: Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A
dataset
posted on 2024-05-03, 10:00 authored by Arash Mahajerin, Imi Faghmous, Peter Kuebler, Monet Howard, Tao Xu, Carlos Flores, Tiffany Chang, Francis NissenThese are peer-reviewed supplementary materials for the article 'Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A' published in the Journal of Comparative Effectiveness Research.
- Supplementary Table 1: Code listings
